Proctocolitis
Conditions
Interventions
Intervention program with educational and behavioral measures
Intervention Program
The program will last 6 months, with each intervention having its frequency as listed below.
Participants in the CG
- printed educational booklet (Appendix 8) will be presented presenting basic contents on the RCU and the importance of adherence to the prescribed drug treatment, prepared by the research team based
- will be targeted on the drugs prescribed for RCU and available for dispensing in the FIMAE (Appendix 10) according to the list of clinical protocols [5]. The verbal guidelines will follow the roadma
Behavioural
Other
Sponsors
Universidade do Estado da Bahia
Programa de Pós-Graduação em Ciências Farmacêuticas - PPGFARMA
Eligibility
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Patients diagnosed with ulcerative colitis (UC); at least 3 months of active registration in the Farmácia Integrada do Medicamento na Atenção Especializada(FIMAE); prescribed with at least 01 medicine to treat UC; of the same age or over 18 years; able to respond to the research tools; agrees to sign the Informed Consent Form (TCLE); assisted by outpatient clinics of Inflammatory Bowel Disease (IBD) at the Hospital Geral Roberto Santos(HGRS) or Hospital Universitário Professor Edgard Santos HUPES); owns a cell phone.
Exclusion criteria
Exclusion criteria: Patients classified as adherents.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The occurrence (incidence) of the primary outcome of the study (non-adherence) will be calculated by the ratio of the total non-adherent participants to the total number of participants in the group, multiplied by 100, calculated separately for the intervention and comparison groups. Non-adherence will be measured using the Morisky-Green-Levine Test. The relative risk (RR) with the respective 95% confidence interval (95% CI) will be used as a measure of effectiveness, obtained by the ratio between the incidence of the intervention group and the incidence of the comparative group. | — |
Secondary
| Measure | Time frame |
|---|---|
| Quality of life will be compared between the intervention groups and the control group, measured by the global score punctuated by the Brazil SF-36 instrument, before and after the intervention program applied for 6 months. The relative risk (RR) with the respective 95% confidence interval (95% CI) will be used as a measure of effectiveness, obtained by the ratio between the incidence of the intervention group and the incidence of the comparative group.;The clinical status of ulcerative colitis, measured by the Lichtiger Index, will be compared between the intervention and control groups, before and after intervention programme applied during 6 months. The relative risk (RR) with the respective 95% confidence interval (95% CI) will be used as a measure of effectiveness, obtained by the ratio between the incidence of the intervention group and the incidence of the comparative group. | — |
Countries
Brazil
Contacts
Public ContactGenoile Oliveira Silva
Programa de Pós-Graduação em Ciências Farmacêuticas - PPGFARMA
Outcome results
None listed